FDA Import Refusal SCS-0353070-8/11/1 — SANOFI AVENTIS R & D
The FDA refused shipment SCS-0353070-8/11/1 from SANOFI AVENTIS R & D (France) on May 19, 2020. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- May 19, 2020
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75